Psychedelics MindBio Therapeutics uses AI speech analysis to see if you’ve taken its LSD drug The biopharma operator's lead drug candidate, MB22001, was created for microdosing Rowan DunneJanuary 24, 2025
Psychedelics MindBio Therapeutics receives approval for LSD study for major depression The study has been approved by the Clinical Trials Registry Rowan DunneMay 24, 2023